LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 101 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q2 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $72,161 | -16.3% | 61,153 | 0.0% | 0.00% | – |
Q2 2023 | $86,226 | -6.1% | 61,153 | +2.5% | 0.00% | – |
Q1 2022 | $91,873 | -50.6% | 59,658 | -21.6% | 0.00% | – |
Q4 2021 | $186,000 | -1.6% | 76,068 | +1.4% | 0.00% | – |
Q3 2021 | $189,000 | -14.9% | 74,991 | -3.9% | 0.00% | – |
Q2 2021 | $222,000 | +221.7% | 78,044 | -6.3% | 0.00% | – |
Q1 2020 | $69,000 | +115.6% | 83,293 | +128.2% | 0.00% | – |
Q4 2019 | $32,000 | – | 36,503 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BROADWOOD CAPITAL INC | 34,935,485 | $39,477,000 | 3.01% |
Raffles Associates | 2,080,536 | $2,351,000 | 2.51% |
Defender Capital, LLC. | 5,184,035 | $5,862,000 | 2.30% |
Prescott General Partners LLC | 1,851,851 | $2,093,000 | 0.16% |
DAFNA Capital Management LLC | 140,000 | $158,000 | 0.04% |
Fort Sheridan Advisors LLC | 83,931 | $95,000 | 0.03% |
Long Focus Capital Management, LLC | 215,000 | $243,000 | 0.02% |
XTX Topco Ltd | 72,807 | $82,000 | 0.02% |
Ergoteles LLC | 490,895 | $555,000 | 0.02% |
Beirne Wealth Consulting Services, LLC | 45,000 | $51,000 | 0.02% |